Author: Ravi Shankar

WILMINGTON, Mass., Oct. 21, 2026 (GLOBE NEWSWIRE) — UniFirst Corporation (NYSE: UNF) (the “Company,” “UniFirst” or “we”) today reported results for its fourth quarter and full year ended August 29, 2026, as compared to the corresponding periods in the prior fiscal year.

Fourth Quarter 2026 Consolidated Financial Results

• Consolidated revenues for the fourth quarter increased 5.0% to $645.0 million, driven primarily by organic growth in the core Uniform & Facility Service Solutions segment.
• Operating income and Adjusted EBITDA were $41.7 million and $94.9 million, respectively, compared to $49.6 million and $88.1 million, respectively, in the fourth quarter of fiscal 2025.
• Operating margin was 6.5% of revenues compared to 8.1% of revenues in the prior year period.
• Adjusted EBITDA margin was 14.7% of revenues compared to 14.3% of revenues in the prior year period.
• Net income was $34.7 million compared to $41.0 million in the prior year period and diluted earnings per share was $1.90 compared to $2.23 in the prior year period.
• The quarterly tax rate was 19.8% compared to 20.2% in the prior year period.

The Company’s financial results for the fourth quarter of fiscal 2026 included approximately $14.4 million of costs associated with the proposed merger with Cintas Corporation (“Cintas”), consisting primarily of legal, advisory and other professional service fees (“Transaction-related Costs”). In addition, the Company’s results for the fourth quarter of fiscal 2026 and 2025 included approximately $2.8 million and $1.4 million, respectively, of costs related to its enterprise resource planning project (“Key Initiative”). In the fourth quarter of fiscal 2026 and 2025, these costs decreased:

• Operating income by $17.3 million and $1.4 million, respectively.
• Adjusted EBITDA by $2.8 million and $1.4 million, respectively.
• Net income by $12.9 million and $1.1 million, respectively.
• Diluted earnings per share by $0.71 and $0.05, respectively.

Fiscal 2026 Consolidated Financial Results

• Consolidated revenues increased 3.7% to $2.523 billion.
• Operating income and Adjusted EBITDA were $136.0 million and $327.1 million, respectively, compared to $184.5 million and $336.8 million, respectively, in fiscal 2025.
• Operating margin was 5.4% of revenues compared to 7.6% of revenues in fiscal 2025.
• Adjusted EBITDA margin was 13.0% of revenues compared to 13.8% of revenues in fiscal 2025.
• Net income was $109.5 million compared to $148.3 million in fiscal 2025 and diluted earnings per share was $6.02 compared to $7.98 in the prior year period.

The Company’s financial results for the full year of fiscal 2026 included approximately $37.2 million of Transaction-related Costs. The Company’s results for the full years of fiscal 2026 and 2025 included approximately $13.3 million and $6.8 million, respectively, of costs directly attributable to its Key Initiative. The effect of these items on the full years of fiscal 2026 and 2025 combined to decrease:

• Operating income by $50.5 million and $6.8 million, respectively.
• Adjusted EBITDA by $13.3 million and $6.8 million, respectively.
• Net income by $37.9 million and $5.1 million, respectively.
• Diluted earnings per share by $2.08 and $0.28, respectively.

Steven Sintros, UniFirst President and Chief Executive Officer, said, “We are pleased with how we closed the fiscal year with a solid fourth quarter delivering improved growth and profitability. We remain focused on caring for our customers and communities, supporting our Team Partners, and demonstrating UniFirst’s compelling value to both new and existing customers.”

Mr. Sintros continued, “I want to thank our thousands of Team Partners for their continued commitment to Always Deliver for our customers, one another, and UniFirst.”

Q4 2026 Segment Reporting Results

Uniform & Facility Service Solutions

• Revenues for the quarter increased 4.5% to $585.4 million compared to $560.1 million in the prior year.
• Organic growth, which excludes the effect of acquisitions and fluctuations in the Canadian dollar, was 4.6%.
• New customer account acquisitions were solid during the quarter and customer retention rates continued to improve, building on the year-to-date progress that the Company has seen in these areas.
• Operating margin was 6.8% compared to 8.3% in the prior period and Adjusted EBITDA margin was 15.5% compared to 14.8% in the prior period.
• The Transaction-related Costs and Key Initiative costs were both recorded to this segment and decreased both operating and Adjusted EBITDA margins in the fourth quarter of fiscal 2026 by 3.0% and 0.5%, respectively. Key Initiative costs in the prior year period decreased both operating and Adjusted EBITDA margins by 0.2%.
• The segment’s operating and Adjusted EBITDA margin comparison in the fourth quarter of fiscal 2026 benefited from lower merchandise and selling costs as a percentage of revenues. These benefits were partially offset by higher production and healthcare claims expenses.

First Aid & Safety Solutions

• Revenues increased 13.0% to $35.2 million compared to $31.1 million in the prior year period.
• The segment reported an operating loss of $1.5 million and an Adjusted EBITDA loss of $0.1 million.
• The segment’s results again reflected the investments the Company has made to drive growth in its First Aid van business.

Other

• Revenues for the quarter increased 5.3% to $24.5 million compared to $23.3 million in the prior year period. The segment had strong growth in its European operations which was partially offset by the continued wind-down of a large refurbishment project and fewer reactor outages.
• Operating income and Adjusted EBITDA were $3.3 million and $4.2 million, respectively.
• This segment consists of the Company’s nuclear solutions and due to the nature of the nuclear industry its results are often affected by seasonality, the timing and duration of power reactor outages and project-based activities.

Balance Sheet and Capital Allocation

• Cash and cash equivalents totaled $192.1 million, and the Company had no long-term debt outstanding as of August 29, 2026.
• The Company paid dividends to shareholders of $25.2 million in fiscal 2026, an increase of 2.1% from the prior year.
• During fiscal 2026, the Company repurchased 194,100 shares of its Common Stock for approximately $31.7 million. As of August 29, 2026, the Company had $8.9 million remaining under its existing share repurchase authorization.

Transaction Update

On July 2, 2026, each of UniFirst and Cintas received a Supplementary Information Request (“SIR”) from the Canadian Competition Bureau (the “CCB”) in connection with the CCB’s review of the transaction contemplated by the Merger Agreement (as defined in the Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on March 11, 2026). On September 29, 2026, each of UniFirst and Cintas certified to the CCB that it has completed its response to the SIR.

On October 2, 2026, each of UniFirst and Cintas certified to the Federal Trade Commission (“FTC”) that it has substantially complied with the Second Request (as defined in the Form 10-Q filed with the SEC on July 8, 2026). On October 2, 2026, UniFirst and Cintas entered into a timing agreement with the FTC pursuant to which UniFirst and Cintas agreed, among other things, not to consummate the transaction prior to December 11, 2026 unless they have received written notice from the FTC prior to such date that the FTC has closed its investigation of the transaction.

The transaction is expected to close prior to the end of calendar year 2026, subject to satisfaction or waiver of customary closing conditions and receipt of required regulatory approvals.

As previously announced, due to the pending transaction with Cintas, UniFirst is no longer providing financial guidance or hosting quarterly conference calls regarding its financial results.

About UniFirst Corporation
Headquartered in Wilmington, Mass., UniFirst Corporation (NYSE: UNF) is a North American leader in the supply and servicing of uniform and workwear programs, facility service products, as well as first aid and safety supplies and services. Together with its subsidiaries, the Company also manages specialized garment programs for the cleanroom and nuclear industries. In addition to partnering with leading brands, UniFirst manufactures its own branded workwear, protective clothing, and floorcare products at its five company-owned ISO-9001-certified manufacturing facilities. With more than 270 service locations, over 300,000 customer locations, and 15,000-plus employee Team Partners, the Company outfits more than 2 million workers every day. For more information, contact UniFirst at 888.296.2740 or visit UniFirst.com.

Forward-Looking Statements Disclosure

This public announcement contains forward-looking statements within the meaning of the federal securities laws that reflect the Company’s current views with respect to future events and financial performance, including statements regarding the transaction between UniFirst and Cintas (the “Transaction”). Forward-looking statements contained in this public announcement are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995 and may be identified by words such as “guidance,” “outlook,” “estimates,” “anticipates,” “projects,” “plans,” “expects,” “intends,” “believes,” “seeks,” “could,” “should,” “may,” “will,” “strategy,” “objective,” “assume,” “strive,” “design,” “assumption,” “vision,” “approximate,” or the negative versions thereof, and similar expressions and by the context in which they are used. Such forward-looking statements are based upon our current expectations and speak only as of the date made. Such statements are highly dependent upon a variety of risks, uncertainties and other important factors that could cause actual results to differ materially from those reflected in such forward-looking statements.

The following Transaction-related factors, among others, could cause actual results to differ materially from those expressed in or implied by forward-looking statements: the occurrence of any event, change, or other circumstance that could give rise to the right of one or both of the parties to terminate the definitive merger agreement between Cintas and UniFirst; the outcome of any legal proceedings that may be instituted against Cintas or UniFirst; the possibility that the Transaction does not close when expected or at all because required regulatory, shareholder, or other approvals and other conditions to closing are not received or satisfied on a timely basis or at all (and the risk that seeking or obtaining such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the Transaction); the risk that the benefits from the Transaction may not be fully realized or may take longer to realize than expected, including as a result of changes in, or problems arising from, general economic and market conditions, interest and exchange rates, monetary policy, trade policy (including tariff levels), laws and regulations and their enforcement, and the degree of competition in the geographic and business areas in which Cintas and UniFirst operate; any failure to promptly and effectively integrate the businesses of Cintas and UniFirst; the possibility that the Transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events; reputational risk and potential adverse reactions of Cintas’ or UniFirst’s customers, employees or other business partners, including those resulting from the announcement, pendency or completion of the Transaction; the dilution caused by Cintas’ issuance of additional shares of its capital stock in connection with the Transaction; changes in the trading price of Cintas’ or UniFirst’s capital stock; and the diversion of management’s attention and time to the Transaction from ongoing business operations and opportunities.

Additional factors include, but are not limited to, uncertainties caused by an economic recession or other adverse economic conditions, including, without limitation, as a result of elevated inflation or interest rates or extraordinary events or circumstances such as geopolitical conflicts like the conflicts between Russia and Ukraine and the United States and Iran and other disruption in the Middle East and their impact on our customers’ businesses and workforce levels, disruptions of our business and operations, including limitations on, or closures of, our facilities, or the business and operations of our customers or suppliers in connection with extraordinary events or circumstances, uncertainties regarding our ability to consummate acquisitions and successfully integrate acquired businesses and the performance of such businesses, uncertainties regarding any existing or newly-discovered expenses and liabilities related to environmental compliance and remediation, any adverse outcome of pending or future contingencies or claims, our ability to compete successfully without any significant degradation in our margin rates, seasonal and quarterly fluctuations in business levels, our ability to preserve positive labor relationships and avoid becoming the target of corporate labor unionization campaigns that could disrupt our business, the effect of currency fluctuations on our results of operations and financial condition, our dependence on third parties to supply us with raw materials, which such supply could be severely disrupted as a result of extraordinary events or circumstances such as the conflict between Russia and Ukraine and the United States and Iran, any loss of key management or other personnel, increased costs as a result of any changes in federal, state, international or other laws, rules and regulations or governmental interpretation of such laws, rules and regulations, uncertainties regarding, or adverse impacts from continued high price levels of natural gas, electricity, fuel and labor or increases in such costs, the negative effect on our business from sharply depressed oil and natural gas prices, the continuing increase in domestic healthcare costs, increased workers’ compensation claim costs, increased healthcare claim costs, our ability to retain and grow our customer base, demand and prices for our products and services, fluctuations in our nuclear business, political or other instability, supply chain disruption or infection among our employees in Mexico and Nicaragua where our principal garment manufacturing plants are located, our ability to properly and efficiently design, construct, implement and operate a new enterprise resource planning computer system, interruptions or failures of our information technology systems, including as a result of cyber-attacks, additional professional and internal costs necessary for compliance with any changes in or additional SEC, New York Stock Exchange and accounting or other rules, strikes and unemployment levels, our efforts to evaluate and potentially reduce internal costs, the impact of U.S. and foreign trade policies and tariffs or other impositions on imported goods on our business, results of operations and financial condition, our ability to successfully implement our business strategies and processes, including our capital allocation strategies, our ability to successfully remediate the material weakness in internal control over financial reporting disclosed in our Annual Report on Form 10-K for the year ended August 30, 2025 and the other factors described under Part I, Item 1A. “Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended August 30, 2025, Part II, Item 1A. “Risk Factors” and elsewhere in our subsequent Quarterly Reports on Form 10-Q and in our other filings with the SEC. We undertake no obligation to update any forward-looking statements to reflect events or circumstances arising after the date on which they are made.

Consolidated Statements of Income
(Unaudited)

		Thirteen Weeks Ended								Fifty-two Weeks Ended
(In thousands, except per share data)		August 29, 2026				August 30, 2025				August 29, 2026				August 30, 2025
Revenues		$	645,005			$	614,447			$	2,523,230			$	2,432,352
Operating expenses:
Cost of revenues (1)			403,890				382,012				1,600,281				1,542,400
Selling and administrative expenses (1)			163,769				146,980				644,913				565,099
Depreciation and amortization			35,654				35,879				141,992				140,355
Total operating expenses			603,313				564,871				2,387,186				2,247,854
Operating income			41,692				49,576				136,044				184,498
Other (income) expense:
Interest income, net			(1,950	)			(2,348	)			(7,234	)			(9,770	)
Other expense (income), net			331				513				1,205				(1,107	)
Total other income, net			(1,619	)			(1,835	)			(6,029	)			(10,877	)
Income before income taxes			43,311				51,411				142,073				195,375
Provision for income taxes			8,584				10,384				32,583				47,104
Net income		$	34,727			$	41,027			$	109,490			$	148,271
Income per share – Basic:
Common Stock		$	2.00			$	2.32			$	6.30			$	8.33
Class B Common Stock		$	1.60			$	1.86			$	5.04			$	6.66
Income per share – Diluted:
Common Stock		$	1.90			$	2.23			$	6.02			$	7.98
Income allocated to – Basic:
Common Stock		$	29,049			$	34,420			$	91,595			$	124,551
Class B Common Stock		$	5,678			$	6,607			$	17,895			$	23,720
Income allocated to – Diluted:
Common Stock		$	34,727			$	41,027			$	109,490			$	148,271
Weighted average shares outstanding – Basic:
Common Stock			14,534				14,823				14,545				14,961
Class B Common Stock			3,551				3,552				3,551				3,560
Weighted average shares outstanding – Diluted:
Common Stock			18,250				18,438				18,196				18,581

(1)		Exclusive of depreciation on the Company’s property, plant and equipment and amortization on its intangible assets.

Condensed Consolidated Balance Sheets
(Unaudited)

(In thousands)		August 29, 2026				August 30, 2025
Assets
Current assets:
Cash and cash equivalents		$	192,121			$	203,501
Short-term investments			—				5,672
Receivables, net			306,998				285,297
Inventories			146,356				145,197
Rental merchandise in service			244,643				227,720
Prepaid taxes			17,413				7,708
Prepaid expenses and other current assets			60,926				49,508
Total current assets			968,457				924,603
Property, plant and equipment, net			843,589				829,622
Goodwill			675,385				657,748
Customer contracts and other intangible assets, net			90,051				105,829
Deferred income taxes			943				977
Operating lease right-of-use assets, net			78,849				70,110
Other assets			213,100				189,266
Total assets		$	2,870,374			$	2,778,155
Liabilities and shareholders’ equity
Current liabilities:
Accounts payable		$	94,522			$	94,980
Accrued liabilities			194,755				176,903
Accrued taxes			196				674
Operating lease liabilities, current			18,808				17,846
Total current liabilities			308,281				290,403
Long-term liabilities:
Accrued liabilities			123,129				128,554
Accrued and deferred income taxes			147,502				135,648
Operating lease liabilities			62,337				54,593
Total liabilities			641,249				609,198
Shareholders’ equity:
Common Stock			1,454				1,468
Class B Common Stock			355				355
Capital surplus			115,369				109,107
Retained earnings			2,133,736				2,079,812
Accumulated other comprehensive loss			(21,789	)			(21,785	)
Total shareholders’ equity			2,229,125				2,168,957
Total liabilities and shareholders’ equity		$	2,870,374			$	2,778,155

Detail of Operating Results
(Unaudited)

	Thirteen Weeks Ended August 29, 2026																Thirteen Weeks Ended August 30, 2025
(In thousands, except percentages)	Uniform & Facility Service Solutions				First Aid & Safety Solutions				Other				Total				Uniform & Facility Service Solutions				First Aid & Safety Solutions				Other				Total
Revenues	$	585,354			$	35,177			$	24,474			$	645,005			$	560,072			$	31,123			$	23,252			$	614,447
Revenue Growth %		4.5	%			13.0	%			5.3	%			5.0	%
Operating Income (Loss) (1), (2)	$	39,963			$	(1,533	)		$	3,262			$	41,692			$	46,567			$	473			$	2,536			$	49,576
Operating Margin		6.8	%			-4.4	%			13.3	%			6.5	%			8.3	%			1.5	%			10.9	%			8.1	%
Adjusted EBITDA (1), (2)	$	90,805			$	(124	)		$	4,175			$	94,856			$	83,098			$	1,511			$	3,457			$	88,066
Adjusted EBITDA Margin		15.5	%			-0.4	%			17.1	%			14.7	%			14.8	%			4.9	%			14.9	%			14.3	%

(1)		The Company’s financial results for the fourth quarter of fiscal 2026 included approximately $17.3 million of costs related to its Key Initiative and Transaction-related Costs, compared to approximately $1.4 million of Key Initiative costs in the fourth quarter of fiscal 2025.
(2)		The Key Initiative and Transaction-related Costs decreased Uniform & Facility Service Solutions’ segment operating margin for the fourth quarters of fiscal 2026 and 2025 by 3.0% and 0.2%, respectively. The Key Initiative costs decreased both Uniform & Facility Service Solutions’ segment Adjusted EBITDA margin for the fourth quarters of fiscal 2026 and 2025 by 0.5% and 0.2%, respectively.

	Fifty-two Weeks Ended August 29, 2026																Fifty-two Weeks Ended August 30, 2025
(In thousands, except percentages)	Uniform & Facility Service Solutions				First Aid & Safety Solutions				Other				Total				Uniform & Facility Service Solutions				First Aid & Safety Solutions				Other				Total
Revenues	$	2,295,801			$	127,023			$	100,406			$	2,523,230			$	2,218,562			$	114,586			$	99,204			$	2,432,352
Revenue Growth %		3.5	%			10.9	%			1.2	%			3.7	%
Operating Income (Loss) (3), (4)	$	126,340			$	(4,589	)		$	14,293			$	136,044			$	168,502			$	853			$	15,143			$	184,498
Operating Margin		5.5	%			-3.6	%			14.2	%			5.4	%			7.6	%			0.7	%			15.3	%			7.6	%
Adjusted EBITDA (3), (4)	$	308,339			$	732			$	17,997			$	327,068			$	313,198			$	4,784			$	18,788			$	336,770
Adjusted EBITDA Margin		13.4	%			0.6	%			17.9	%			13.0	%			14.1	%			4.2	%			18.9	%			13.8	%

(3)		The Company’s financial results for the full fiscal year 2026 included approximately $50.5 million of costs related to its Key Initiative and the Transaction-related Costs, compared to approximately $6.8 million of Key Initiative costs in the full fiscal year 2025.
(4)		The Key Initiative and Transaction-related Costs decreased Uniform & Facility Service Solutions’ segment operating margin for the full fiscal years 2026 and 2025 by 2.2% and 0.3%, respectively. The Key Initiative costs decreased Uniform & Facility Service Solutions’ segment Adjusted EBITDA margin for the full fiscal years 2026 and 2025 by 0.6% and 0.3%, respectively.

Consolidated Statements of Cash Flows
(Unaudited)

(In thousands)		August 29, 2026				August 30, 2025
Cash flows from operating activities:
Net income		$	109,490			$	148,271
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization (1)			141,992				140,355
Share-based compensation			13,062				12,173
Accretion on environmental contingencies			1,404				1,280
Accretion on asset retirement obligations			1,072				875
Deferred income taxes			10,281				3,897
Loss (gain) on sale of property and equipment			309				(2,117	)
Other			214				448
Changes in assets and liabilities, net of acquisitions:
Receivables, less reserves			(21,320	)			(6,478	)
Inventories			(445	)			12,318
Rental merchandise in service			(16,759	)			10,039
Prepaid expenses and other current assets and Other assets			(15,545	)			(24,330	)
Accounts payable			(2,005	)			2,333
Accrued liabilities			(7,890	)			(8,774	)
Prepaid and accrued income taxes			(8,575	)			6,582
Net cash provided by operating activities			205,285				296,872
Cash flows from investing activities:
Acquisition of businesses, net of cash acquired			(24,578	)			(11,911	)
Capital expenditures, including capitalization of software costs			(134,519	)			(154,345	)
Purchases of investments			(5,664	)			(20,406	)
Maturities of investments			11,426				28,356
Proceeds from sale of assets			798				3,259
Net cash used in investing activities			(152,537	)			(155,047	)
Cash flows from financing activities:
Payment of contingent consideration			(1,670	)			—
Payment of deferred financing costs			—				(1,164	)
Proceeds from exercise of share-based awards			5				4
Taxes withheld and paid related to net share settlement of equity awards			(5,178	)			(4,473	)
Repurchase of Common Stock			(32,736	)			(70,895	)
Payment of cash dividends			(25,151	)			(24,625	)
Net cash used in financing activities			(64,730	)			(101,153	)
Effect of exchange rate changes			602				1,258
Net (decrease) increase in cash and cash equivalents			(11,380	)			41,930
Cash and cash equivalents at beginning of period			203,501				161,571
Cash and cash equivalents at end of period		$	192,121			$	203,501
Supplemental Disclosure of Operating Cash Flow Information:
Cash paid for transaction-related expense (2)		$	22,489			$	—

(1)		Depreciation and amortization for the full year of fiscal 2026 and 2025 included approximately $15.5 million and $17.0 million, respectively, of non-cash amortization expense recognized on acquisition-related intangible assets.
(2)		Cash paid for transaction-related expenses in fiscal 2026 was $22.5 million.

Reconciliation of GAAP to Non-GAAP Financial Measures

The Company reports its consolidated financial results in accordance with generally accepted accounting principles (“GAAP”). To supplement the Company’s consolidated financial results in this press release, the Company also presents Adjusted EBITDA and Adjusted EBITDA margin, which are non-GAAP financial measures. The Company defines Adjusted EBITDA as net income before interest, income taxes, depreciation and amortization, further adjusted for share-based compensation expense and other items impacting the comparability of the Company’s underlying operating performance between periods. Adjusted EBITDA margin is defined as Adjusted EBITDA for a period divided by revenue for the same period.

The Company believes these non-GAAP financial measures provide useful supplemental information regarding the performance of the Company and its segments to both management and investors. In addition, by excluding certain items, these non-GAAP financial measures enable management and investors to further evaluate the underlying operating performance of the Company.

Supplemental reconciliations of the Company’s consolidated net income on a GAAP basis to Adjusted EBITDA and Adjusted EBITDA margin are presented in the following table. Investors are encouraged to review the reconciliations of the non-GAAP financial measures to their most directly comparable GAAP financial measures, which are provided below. Adjusted EBITDA and Adjusted EBITDA margin should be considered in addition to, and not as substitutes for, or in isolation from, measures prepared in accordance with GAAP.

The Company does not allocate its provision for income taxes to its business segments and as a result, presents it in a separate column in the following tables.

	Thirteen Weeks Ended August 29, 2026
(In thousands, except percentages)	Uniform & Facility Service Solutions				First Aid & Safety Solutions				Other				Unallocated Adjustments				Total
Revenue	$	585,354			$	35,177			$	24,474			$	—			$	645,005
Net income	$	41,582			$	(1,533	)		$	3,262			$	(8,584	)		$	34,727
Provision for income taxes		—				—				—				8,584				8,584
Interest income, net		(1,950	)			—				—				—				(1,950	)
Depreciation and amortization		33,516				1,376				762				—				35,654
Share-based compensation expense		3,212				33				151				—				3,396
Non-operating adjustments (1)		14,445				—				—				—				14,445
Adjusted EBITDA	$	90,805			$	(124	)		$	4,175			$	—			$	94,856
Adjusted EBITDA Margin		15.5	%			(0.4	%)			17.1	%							14.7	%

(1)		Represents Transaction-related Costs in connection with the proposed merger with Cintas.

	Thirteen Weeks Ended August 30, 2025
(In thousands, except percentages)	Uniform & Facility Service Solutions				First Aid & Safety Solutions				Other				Unallocated Adjustments				Total
Revenue	$	560,072			$	31,123			$	23,252			$	—			$	614,447
Net income	$	48,402			$	473			$	2,536			$	(10,384	)		$	41,027
Provision for income taxes		—				—				—				10,384				10,384
Interest income, net		(2,348	)			—				—				—				(2,348	)
Depreciation and amortization		34,086				1,008				785				—				35,879
Share-based compensation expense		2,958				30				136				—				3,124
Adjusted EBITDA	$	83,098			$	1,511			$	3,457			$	—			$	88,066
Adjusted EBITDA Margin		14.8	%			4.9	%			14.9	%							14.3	%

	Fifty-two Weeks Ended August 29, 2026
(In thousands, except percentages)	Uniform & Facility Service Solutions				First Aid & Safety Solutions				Other				Unallocated Adjustments				Total
Revenue	$	2,295,801			$	127,023			$	100,406			$	—			$	2,523,230
Net income (loss)	$	132,369			$	(4,589	)		$	14,293			$	(32,583	)		$	109,490
Provision for income taxes		—				—				—				32,583				32,583
Interest income, net		(7,234	)			—				—				—				(7,234	)
Depreciation and amortization		133,725				5,191				3,076				—				141,992
Share-based compensation expense		12,304				130				628				—				13,062
Non-operating adjustments (2)		37,175				—				—				—				37,175
Adjusted EBITDA	$	308,339			$	732			$	17,997			$	—			$	327,068
Adjusted EBITDA Margin		13.4	%			0.6	%			17.9	%							13.0	%

(2)		Primarily represents costs related to shareholder engagement and proxy-related matters in connection with the Company’s 2026 annual meeting of shareholders and Transaction-related Costs in connection with the proposed merger with Cintas.

	Fifty-two Weeks Ended August 30, 2025
(In thousands, except percentages)	Uniform & Facility Service Solutions				First Aid & Safety Solutions				Other				Unallocated Adjustments				Total
Revenue	$	2,218,562			$	114,586			$	99,204			$	—			$	2,432,352
Net income	$	179,379			$	853			$	15,143			$	(47,104	)		$	148,271
Provision for income taxes		—				—				—				47,104				47,104
Interest income, net		(9,770	)			—				—				—				(9,770	)
Depreciation and amortization		133,420				3,815				3,120				—				140,355
Share-based compensation expense		11,532				116				525				—				12,173
Gain on the sale of a non-operating property		(2,792	)			—				—				—				(2,792	)
Non-operating adjustments (3)		1,429				—				—				—				1,429
Adjusted EBITDA	$	313,198			$	4,784			$	18,788			$	—			$	336,770
Adjusted EBITDA Margin		14.1	%			4.2	%			18.9	%							13.8	%

(3)		Primarily represent one-time costs incurred related to the hiring and on-boarding of the Company’s former Chief Operating Officer, Kelly Rooney, and for the transition of Michael Croatti from his role as Executive Vice President, Operations.

Investor Relations Contact
Shane O’Connor, Executive Vice President & CFO
UniFirst Corporation
978-658-8888
shane_oconnor@unifirst.com

ROCKAWAY, N.J., Oct. 21, 2026 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet MicroCap Toronto 2026 Powered by MicroCapClub being held at the Arcadian Court & Loft.  Joshua Lev, Co-CEO, President and CFO, will deliver a presentation and host one-on-one investor meetings throughout the conference.

Conference Details:

Dates:  October 27-29
Company Presentation:  Wednesday, October 28 at 9:30 am ET
Location:  Arcadian Court & Loft, 401 Bay St., Simpson Tower, 8th Floor Toronto, ON, M5H 2Y4
Webcast:  https://event.summitcast.com/view/iiVo9HYfz9sL9CC5m4Dgpv/N22s45azRsLw3U5aeUR5NF

If you would like to book one-on-one investor meetings with electroCore and attend Planet MicroCap Toronto 2026, please register at https://planetmicrocap.com.

About electroCore, Inc.

electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore® non-invasive vagus nerve stimulation (nVNS) and Quell® neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga™ and TAC-STIM™ nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.

For more information, visit www.electrocore.com.

Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com

Agreement generates non-dilutive funding; PEA evaluating direct shipping planned for H1 2027

VANCOUVER, British Columbia, Oct. 21, 2026 (GLOBE NEWSWIRE) — Blue Jay Gold Corp. (TSXV: JAY) (OTCQB: JAYGF) (FSE: JAY) (“Blue Jay” or the “Company”) is pleased to announce a materials purchase agreement with Ocean Partners UK Limited (“Ocean Partners”), an international trader of base and precious metal concentrates, in support of its Steller Gold Project (“Steller” or the “Project”), located 55 km south of Whitehorse, Yukon. The materials purchase agreement (the “Agreement”) provides for the sale of the Company’s remediation material (the “Remediation Material”) and gives Ocean Partners exclusivity over the purchase of any further remediation stockpile and similar material from Steller during 2027.

The Remediation Material consists of surface stockpile material extracted by a previous operator during underground development at Skukum Creek. This material will be shipped to the Port of Skagway under the agreement with Ocean Partners.

Highlights

• Work that Should be Done: Removing this material reduces the historical legacy stockpiles at Steller and advances part of the Company’s remediation program. Shipping it to Skagway makes the remediation work more sustainable, turning a remediation obligation into a source of non-dilutive capital.
• 2027 Exclusivity: Ocean Partners will have exclusivity over the purchase of any further remediation stockpile and similar material from Steller during 2027.
• PEA Planned: Blue Jay intends to complete a Preliminary Economic Assessment (“PEA”) in the first half of 2027 evaluating a direct shipping ore (“DSO”) option for the current Steller Mineral Resource under a life-of-mine scenario.
• Infrastructure Advantage: Steller is connected by road to both Whitehorse and the deep-water port of Skagway, Alaska. The Project is approximately 165 km by road from the point where the material will be delivered.
• Advance Payment on Delivery: Ocean Partners will pay 90% of the estimated value of each shipment shortly after loading, with the balance settled on final weights and assays.

“Projects with past operations often come with legacy stockpiles, and they create an opportunity to use progressive and novel approaches to rehabilitation. At Steller, geography gives us an elegant solution,” said Geordie Mark, CEO of Blue Jay Gold. “Our approach also highlights a part of Steller that is easy to overlook. Many projects have no simple way to deal with stockpiles. At Steller, we can truck the material from site to a nearby port and load it onto a ship. Doing this with Ocean Partners means the work generates capital for the Company instead of consuming it, and an Agreement that extends through 2027 shows that Ocean Partners sees longer-term value in Steller. This work also gives us an early indication of whether a lower-impact direct shipping approach could work at Steller. That access is a real advantage for the Project, and it is why we intend to complete a PEA in the first half of 2027 that evaluates development options, including direct shipping. This shipment gives us a working test of the logistics that approach would rely on, while our exploration capital stays focused on drilling.”

Brent Omland, CEO of Ocean Partners, added, “Direct shipping of remediation material is one of the products Ocean Partners trades, and Steller has the attributes, with its high-grade gold and silver mineralization, a past-producing mine and road access to a deep-water port, that make it a good fit. The remediation material gives us a practical place to start working together, and our exclusivity through 2027 reflects our confidence in the Project. We look forward to supporting Blue Jay as it advances Steller and considers the options available to bring its material to market.”

Infrastructure and Logistics

Steller is accessed by an approximately 84 km road from Whitehorse and sits approximately 20 km north of the British Columbia border. The material will be collected and trucked by existing highway to Skagway, Alaska, an established port on the Pacific coast. Delivery would take place at Skagway and then shipped to Ocean Partners’ facilities.

Materials Purchase Agreement

Under the Agreement, Ocean Partners will purchase 100% of stockpiled and similar material to the end of 2027. Material will be delivered free on board at Skagway, with payment based on a grade-based payability scale. Ocean Partners will advance 90% of the estimated value of each shipment shortly after loading, with the balance settled on final weights and assays.

Preliminary Economic Assessment

Blue Jay intends to complete a PEA in the first half of 2027 that evaluates a DSO option for the current Mineral Resource Estimate at Steller under a life-of-mine scenario. The Mineral Resource Estimate, prepared by P&E Mining Consultants Inc. with an effective date of October 31, 2025, includes Indicated Mineral Resources of 1,372,000 tonnes grading 9.06 g/t AuEq for 400,000 ounces AuEq and Inferred Mineral Resources of 2,166,000 tonnes grading 6.45 g/t AuEq for 449,000 ounces AuEq, at a 3.0 g/t AuEq cut-off¹. Practical experience from shipping the 2026 Remediation Material, including logistics, sampling and commercial terms, is expected to inform the PEA.

The 2026 Remediation Material is not a mineral resource or mineral reserve under National Instrument 43-101 (“NI 43-101”). The Company has not based any decision on a feasibility study of mineral reserves demonstrating economic and technical viability, and there is increased uncertainty and economic and technical risk associated with the bulk sample program.

1. 2026 Technical Report. TECHNICAL REPORT AND UPDATED MINERAL RESOURCE ESTIMATE OF THE STELLER GOLD PROJECT, WHITEHORSE MINING DISTRICT, YUKON TERRITORY, CANADA. P&E Mining Consultants Inc. Effective Date: Oct. 31, 2025. Cut-off: 3.0 g/t AuEq. Au: US$2,850/oz. Ag: US$34.20/oz. AuEq ratio = Au:Ag 85.6:1

Next Steps

Blue Jay expects to ship the Remediation Material in the near term. The Company will engage a consultant and begin work on the PEA this quarter. Blue Jay will continue to evaluate further remediation pathways in consultation with its partners and stakeholders. Proceeds from the sale of the 2026 Remediation Material will be used to fund exploration at Steller and for general working capital.

Qualified Person

The scientific and technical content of this news release has been reviewed and approved by Freeman Smith, P.Geo., VP Exploration of Blue Jay Gold Corp., who is a Qualified Person as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects.

About Ocean Partners

Ocean Partners UK Limited is part of the Ocean Partners group, a leading international trader of base and precious metal concentrates. Headquartered in the United Kingdom, with offices across North America, Europe, Asia and Latin America, Ocean Partners provides marketing, logistics, blending and warehousing, and financing services to metal producers worldwide.

About Blue Jay Gold Corp.

Blue Jay Gold Corp. is a Canadian gold exploration company focused on growing and discovering resources within established gold producing regions in Canada. The Company’s flagship asset is the 100%-owned Steller Gold Project in southern Yukon, an infrastructure-supported, past-producing mine with significant exploration upside and clear near-term catalysts. Blue Jay has also built a portfolio of projects in Ontario. With strategically located assets and a leadership team experienced in geology and capital markets, Blue Jay will advance disciplined, modern exploration programs focused on target definition, resource growth, and new discoveries in known gold-mineralized regions. For more information, please visit: www.bluejaygoldcorp.com.

ON BEHALF OF BLUE JAY GOLD CORP.

signed “Geordie Mark”
Geordie Mark, CEO

For additional information contact:

BLUE JAY GOLD CORP.

Geordie Mark
CEO
Blue Jay Gold Corp.
info@bluejaygoldcorp.com
Phone: (604) 235-4059

Eric Negraeff
Investor Relations
Blue Jay Gold Corp.
eric@bluejaygoldcorp.com
Phone: (604) 235-4059

Cautionary Note Regarding Forward-Looking Statements
Certain statements in this press release contain forward-looking information. Forward-looking information involves risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking information. In addition, the forward-looking statements require management to make assumptions and are subject to inherent risks and uncertainties. There is significant risk that the forward-looking statements will not prove to be accurate, that the management’s assumptions may not be correct and that actual results may differ materially from such forward-looking statements. These statements can be identified by the use of forward-looking terminology (e.g., “expect”, “estimates”, “intends”, “anticipates”, “believes”, “plans”). Forward-looking statements contained in this press release may include, but are not limited to, the terms and completion of the Agreement with Ocean Partners, the timing of shipments and the amount and timing of payments, Ocean Partners’ exclusivity over 2027 material, the timing, scope and results of the PEA, the potential for direct shipping at Steller, the Company’s remediation obligations and the evaluation of further remediation pathways, the use of proceeds, and future business plans of the Company. Such information involves known and unknown risks, including the receipt of regulatory approval, compliance with the bulk sample permit, fluctuations in gold and silver prices, variations in grade and tonnage, penalties for deleterious elements, transportation and port availability and costs, the ability to finalize definitive terms with Ocean Partners, the results of future financing and exploration activities, the interpretation of exploration results and other geological data, or unanticipated costs and expenses and other risks identified by Blue Jay in its public securities filings that may cause actual events to differ materially from current expectations. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Except as required by applicable securities laws and regulation, Blue Jay disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

New Taipei City, Taiwan/San Francisco, CA, Oct. 21, 2026 (GLOBE NEWSWIRE) — Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics, today announced that it will hold a two-day investor events on Saturday, October 24, 2026 in Mountain View, California in Silicon Valley and on Sunday, October 25, 2026 in Irvine, California. The meetings will be conducted in person, with management set to discuss the Company’s recent operational highlights and strategic growth initiatives.

Event Registration

• Saturday, October 24, 2026, from 4:30 PM to 7:30 PM PT in Mountain View, CA.
• Sunday, October 25, 2026, from 5:00 PM to 7:30 PM PT in Irvine, CA.

Investors, analysts, and industry professionals are invited to attend the events. Those interested in meeting with the Company should contact the management team at ir@jyongbio.com.

About Jyong Biotech Ltd.

Headquartered in Taiwan, Jyong Biotech Ltd. is a science-driven biotechnology company committed to developing and commercializing innovative and differentiated new drugs (plant-derived), mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. Since its inception in 2002, the Company has built integrated capabilities that encompass all key functionalities of drug development, including early-stage drug discovery and development, pharmacology, toxicology, clinical trials, regulatory affairs, manufacturing, and commercialization. Leveraging strong research and development capabilities and a proprietary platform, the Company has been developing a series of botanical drug candidates, including its primary botanical drug candidate, BOTRESO^®, another clinical-stage botanical drug candidate, and other preclinical-stage botanical drug candidates. The Company endeavors to develop and supply first-class innovative drugs to meet customers’ health needs and seeks to be a valuable business organization that is held in high esteem by the public. For more information, please visit: https://jyongir.com/.

Forward-Looking Statement

This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other factors discussed in the “Risk Factors” section of the registration statement, prospectuses, annual and interim reports, and other filings with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

For more information, please contact:

Jyong Biotech Ltd.
Email: ir@jyongbio.com
vivi.z@jyongbio.com
Phone: +1 (646) 307-3803

Investor Relations
WFS Investor Relations Inc.
Email: services@wfsir.com
Phone: +1 (628) 283-9214

HONG KONG, Oct. 21, 2026 (GLOBE NEWSWIRE) — Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the “Company”), a leading provider of over-the-counter (“OTC”) pharmaceutical cross-border e-commerce supply chain services in Hong Kong, announced that it expects to implement a 1-for-20 reverse stock split, or consolidation of its issued and unissued Class A ordinary shares and Class B ordinary shares, par value $0.001 per share (the “Ordinary Shares”), effective at the opening of market of October 26, 2026 (the “Reverse Stock Split”). Trading in the Class A Ordinary Shares on a split-adjusted basis will continue on Nasdaq on October 26, 2026 under the symbol “HKPD.” The new CUSIP number for the Company’s Ordinary Shares post-Reverse Stock Split is G6365B112.

Upon the effectiveness of the Reverse Stock Split, every twenty issued and outstanding Ordinary Shares will be consolidated into one Ordinary Shares. The Company’s Ordinary Shares have a par value of $0.001 per share prior to the Reverse Stock Split and will have a par value of $0.02 per share following the Reverse Stock Split. Fractional shares resulting from the Reverse Stock Split will be rounded up to the nearest whole share at a participant level. The Reverse Stock Split affects all shareholders uniformly and will not alter any shareholder’s percentage interest in the Company’s outstanding Ordinary Shares, except for adjustments that may result from the treatment of fractional shares. The Reserves Stock Split was approved by the Company’s board of directors.

The Reverse Stock Split is primarily intended to enable the Company to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. However, there can be no assurance that the Company will regain compliance with such requirement within the applicable compliance period or maintain compliance with Nasdaq’s continued listing requirement thereafter.

About Cellyan Biotechnology Co., Ltd

Cellyan Biotechnology Co., Ltd (f.k.a. Hong Kong Pharma Digital Technology Holdings Limited) offers two main categories of services: (i) OTC pharmaceutical cross-border e-commerce supply chain services through its Hong Kong subsidiary, Joint Cross Border Logistics Company Limited (“Joint Cross Border”), and (ii) OTC pharmaceutical cross-border procurement and distribution through its Hong Kong subsidiary, V-Alliance Technology Supplies Limited.

Through its engagement with OTC pharmaceutical suppliers, logistics companies, and merchants on Chinese e-commerce platforms, Joint Cross Border provides a convenient one-stop solution for Mainland Chinese customers seeking access to OTC pharmaceutical products outside Mainland China. Joint Cross Border’s comprehensive service offerings include pre-consultation, product information review, procuring overseas OTC pharmaceutical products, enlisting OTC pharmaceutical products with the Hong Kong Department of Health, obtaining import and export permits, storing products, packaging, and arranging logistics and end-to-end delivery services for customers. 

Forward-Looking Statements

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. All forward-looking statements, expressed or implied, in this release are based only on information currently available to us and speak only as of the date on which they are made. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions in this release. Except as otherwise required by applicable law, we disclaim any duty to publicly update any forward-looking statement to reflect events or circumstances after the date of this release. These statements are subject to uncertainties and risks, including, but not limited to, the uncertainties related to market conditions, and other factors discussed in our filings with the SEC. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s filings with the SEC. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

For investor and media inquiries please contact:   

Cellyan Biotechnology Co., Ltd
Media Contact: andy@cell-yan.com 
Investor Relations: stella@cell-yan.com   

Initial engineering program is leveraging IMPSA’s decades of nuclear experience to advance engineering and manufacturability of the KRONOS MMR^™ design

New York, N.Y. and Mendoza, Argentina, Oct. 21, 2026 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO” or “the Company”), a leading advanced nuclear micro modular reactor and technology company developing microreactors, nuclear fuel cycle capabilities and nuclear transportation solutions, today announced that it has entered into a Engineering Services Master Agreement (ESMA) with the U.S. subsidiary of IMPSA, one of Argentina’s leading engineering and heavy-manufacturing companies, to support the engineering, design-for-manufacture and potential future fabrication of critical components for NANO Nuclear’s KRONOS MMR^™ Energy System.

The three-year agreement establishes a framework for NANO Nuclear to utilize IMPSA’s extensive experience in nuclear pressure vessels, ASME Section III manufacturing, welding, non-destructive examination, quality assurance and heavy-component fabrication as the KRONOS MMR^™ design progresses toward manufacturing readiness.

The reactor pressure vessel is specifically identified as a principal reactor-component under evaluation by IMPSA. The parties have separately identified reactor cavity cooling systems, spent-fuel storage systems and additional reactor and transportation components as additional areas of potential collaboration.

Initial KRONOS MMR^™ Engineering and Manufacturability Program

Under the ESMA, NANO and IMPSA are beginning with a dedicated KRONOS MMR^™ Design Review and Assessment – Engineering Consulting and Manufacturability Feasibility Study. The initial program provides for an estimated six-month period, supported by a retainer. IMPSA’s work is expected to include an independent review of KRONOS MMR^™ components against applicable ASME Boiler and Pressure Vessel Code Section III requirements and the application of IMPSA’s prior experience engineering and fabricating nuclear pressure vessels and other nuclear components.

The program aims to incorporate manufacturing expertise into the KRONOS MMR^™ design process at an early stage, allowing the companies to identify potential fabrication constraints, inspection limitations, accessibility issues, supply-chain risks and potential design improvements ahead of future manufacturing. As required by NANO, the work may also extend to detailed engineering and fabrication drawings, code-compliant calculations, 3D models and other engineering deliverables.

Figure 1: NANO Nuclear Energy’s engineering team visits IMPSA’s manufacturing facility for a project kickoff meeting

“IMPSA has developed sophisticated nuclear engineering and manufacturing capabilities over many decades, and we see an opportunity to connect that expertise with the next generation of advanced nuclear projects,” said Jay Yu, Founder and Chairman of NANO Nuclear Energy. “Our objective is to build NANO Nuclear with the capabilities needed to commercialize nuclear technology: reactor engineering, manufacturing, fuel, transportation and project execution. Our relationship with IMPSA can strengthen several of those areas at the same time while establishing an important industrial relationship between the United States and Argentina.”

“Advanced reactors have to move from drawings and calculations to modular components that can be manufactured repeatedly, inspected, qualified and assembled,” said James Walker, Chief Executive Officer of NANO Energy. “IMPSA brings more than four decades of nuclear engineering and manufacturing experience and particularly valuable expertise in nuclear pressure vessels and ASME Section III fabrication. Having that manufacturing knowledge applied to KRONOS at this stage is expected to identify constraints earlier, strengthen the design-for-manufacture process and build a much more direct pathway toward future component production.”

The non-exclusive ESMA describes IMPSA as one of the few companies in Latin America certified with ASME N and ASME III N stamps, providing capabilities for the engineering and construction of Class 1 heavy nuclear components.

“This alliance represents a strategic opportunity for IMPSA and for the Argentine nuclear industry,” said Jorge Salcedo Hernández, President of IMPSA. “With decades of experience manufacturing pressure vessels under ASME N-Stamp certification, IMPSA has established itself as one of the few suppliers capable of assessing the manufacturability of nuclear components at an early stage. Our goal is to enable NANO Nuclear to accelerate the KRONOS MMR^™ manufacturing process, advancing toward safer and more efficient nuclear systems.”

Future component fabrication, regional projects or other commercial activities beyond the initial engineering services will remain subject to the results of the engineering work, applicable regulatory requirements and, where required, additional work orders or definitive agreements between the relevant parties.

About IMPSA

IMPSA is a company with more than 115 years of experience across multiple industries, specializing in the design and manufacturing of major components for nuclear power plants and in providing engineering equipment and services that ensure high levels of safety and performance.

For more than 40 years, the company has played an active role in the Argentine nuclear industry’s most significant projects and challenges, combining expertise in manufacturing, engineering and technological innovation. It currently participates in the construction, refurbishment and modernization of nuclear facilities, as well as in the development and manufacturing of small modular reactors (SMRs).

About NANO Nuclear Energy, Inc.

NANO Nuclear Energy Inc. (NASDAQ: NNE) is a North American advanced technology-driven nuclear energy company seeking to become a commercially focused, diversified, and vertically integrated company across five business lines: (i) cutting edge portable and other microreactor technologies, (ii) nuclear fuel supply chain, (iii) nuclear fuel transportation, (iv) nuclear applications for space and (v) nuclear industry consulting services.

Led by a world-class nuclear engineering team, NANO Nuclear’s reactor products in development include the proprietary KRONOS MMR^™ Energy System, a stationary high-temperature gas-cooled reactor that is in construction permit pre-application engagement U.S. Nuclear Regulatory Commission (NRC) in collaboration with University of Illinois Urbana-Champaign, “ZEUS”, a portable solid core battery reactor, and the space focused, portable LOKI MMR^™, each representing advanced developments in clean energy solutions that are portable, on-demand capable, advanced nuclear microreactors.

Advanced Fuel Transportation Inc. (AFT), a NANO Nuclear subsidiary, bolstered by the May 2026 acquisition of Secured Transportation Services (STS), is led by former executives from the largest transportation company in the world and provides nuclear engineering and materials transport services in the U.S. and globally. Through NANO Nuclear, AFT is the exclusive licensee of a patented high-capacity HALEU fuel transportation basket developed by three major U.S. national nuclear laboratories and funded by the Department of Energy.

HALEU Energy Fuel Inc. (HEF), a NANO Nuclear subsidiary, is focusing on the future development of a domestic source for a High-Assay, Low-Enriched Uranium (HALEU) fuel fabrication pipeline for NANO Nuclear’s own microreactors as well as the broader advanced nuclear reactor industry.

NANO Nuclear Space Inc. (NNS), a NANO Nuclear subsidiary, is exploring the potential commercial applications of NANO Nuclear’s developing micronuclear reactor technology in space. NNS is focusing on applications such as the LOKI MMR^™ system and other power systems for extraterrestrial projects and human sustaining environments, and potentially propulsion technology for long haul space missions. NNS’ initial focus will be on cis-lunar applications, referring to uses in the space region extending from Earth to the area surrounding the Moon’s surface.

For more corporate information please visit: https://NanoNuclearEnergy.com/

For further NANO Nuclear information, please contact:

Email: IR@NANONuclearEnergy.com
Business Tel: (212) 634-9206

PLEASE FOLLOW OUR SOCIAL MEDIA PAGES HERE:

NANO Nuclear Energy LINKEDIN
NANO Nuclear Energy YOUTUBE
NANO Nuclear Energy X PLATFORM

Cautionary Note Regarding Forward Looking Statements

This news release and statements of NANO Nuclear’s management and collaborators in connection with this news release contain or may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial performance, and often contain words such as “expects”, “anticipates”, “intends”, “explore,” “plans”, “aim,” “goal,” “believes”, “potential”, “will”, “should”, “could”, “would” or “may” or derivations of these words and other words of similar meaning about the future. In this press release, forward-looking statements include those relating to the anticipated benefits to NANO Nuclear of the new Engineering Services Master Agreement with IMPSA described herein (which benefits may not be achieved) as well as NANO Nuclear’s operational plans and goals generally. These and other forward-looking statements are based on information available to us as of the date of this news release and represent management’s current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors, which may be beyond our control. For NANO Nuclear, particular risks and uncertainties that could cause our actual future results to differ materially from those expressed in our forward-looking statements include but are not limited to the following: (i) risks related to our U.S. Department of Energy (“DOE”), U.S. Nuclear Regulatory Commission (“NRC”), Canadian Nuclear Safety Commission (“CNSC”) or related state or other U.S. or non-U.S nuclear licensing submissions, (ii) risks related the development of new or advanced technology and the acquisition of complementary technology or businesses, including difficulties with design and testing, cost overruns, regulatory delays, integration issues and the development of competitive technology, (iii) our ability to obtain and maintain key vendor, technology and customer contracts and the significant funding necessary to execute on our business plan, (iv) risks related to uncertainty regarding our ability to technologically develop and commercially deploy a competitive advanced nuclear reactor or other technology in the timelines we anticipate, if ever, (v) risks related to the impact of U.S. and non-U.S. government regulation, policies and licensing requirements, including by the DOE, and the NRC, including those associated with the recently enacted ADVANCE Act and the May 23, 2025 Executive Orders seeking to streamline nuclear regulation, and (vi) similar risks and uncertainties associated with the operating a developing business a highly regulated, competitive and rapidly evolving industry, including that our plans may change and we may use our cash on hand faster or in different ways than anticipated as our business requires. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. These factors may not constitute all factors that could cause actual results to differ from those discussed in any forward-looking statement, and NANO Nuclear therefore encourages investors to review other factors that may affect future results in its filings with the SEC, which are available for review at www.sec.gov and at https://ir.nanonuclearenergy.com/financial-information/sec-filings. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.

Attachment

• NANO Nuclear Energy Inc.

Accretive Acquisition Adds Multiple New Markets and Significant Acceleration of Programming-as-a-Service Offering

REDMOND, Wash., Oct. 21, 2026 (GLOBE NEWSWIRE) — Data I/O Corporation (NASDAQ: DAIO) (the “Company”), the leading global provider of data programming equipment, provisioning services and security provisioning for Flash-based microcontrollers, and high density memory devices, today announced that it has completed its previously announced transformational acquisition of V-TEK, Inc. and A&J Programming, Inc. (collectively, “V-TEK”), leading manufacturers of semiconductor handling automation for test and packaging solutions based in Mankato, MN.

“Closing this acquisition marks the first significant milestone set two years ago to expand markets we serve and expand the lines of revenue to make Data I/O a more resilient, profitable and growth-oriented company. The NEW Data I/O becomes real and is materially impactful to its financial performance and growth outlook,” said William Wentworth, President and CEO of Data I/O Corporation. “The acquisition is expected to be accretive to our existing operations. With the acquisition of V-TEK, we will diversify our revenue streams, reducing our reliance on the cyclical nature of the capital equipment markets. We have minimized our reliance on the automotive industry, more than doubled our revenue consolidated, which expands Data I/O into markets such as data center, AI, photonics, industrial automation, medical, military, aerospace and defense. We will continue to innovate and invest in new automation solutions for programming and test. V-TEK’s existing programming business let us accelerate Programming-as-a-Service. Just as important, we are shifting revenue mix adding software and services, which will play a more significant role in next year’s growth plan.”

“We are proud of what the V-TEK team has built, and we believe Data I/O is the right partner to take the business to its next stage,” said Bill Karol on behalf of the selling ownership group. “Our decision to take up to $3 million of the purchase price in Data I/O stock, reflects our conviction in the combined company. With broader end markets, a growing service business and meaningful new scale, we believe there is the potential for significant upside ahead and look forward to participating in it as shareholders.”

“Each of our three companies brings a distinct strength, and together they are covering the data provisioning supply chain,” said Mitch Jacobs, President, V-TEK, Inc. and, following the acquisition, Senior Vice President, Data I/O Corporation. “V-TEK’s handling, test, inspection and packaging systems, A&J Programming’s service expertise and Data I/O’s programming and security technology fit naturally together. That combination lets us expand our solutions with modular and customized systems, flexible service offerings, and global distribution and on-site support. It’s a stronger offering for customers and a real growth platform for the business.”

Additional benefits from the acquisition of V-TEK include, but are not limited to, significant sales synergies across all revenue lines and channel partners, operating leverage synergies, and lower-cost domestic manufacturing, tooling and other capabilities that will improve margins over time while increasing scale and scope for future growth. Following the acquisition, V-TEK will operate as a subsidiary of Data I/O.

Transaction Terms

Total consideration was approximately $23 million, paid in a combination of $20 million in cash and $3 million in Data I/O common stock. A portion of the cash consideration came from the closing of the private placement announced on October 19, 2026.

StoneX Financial Inc. served as M&A advisor to the Company, and Dorsey & Whitney LLP served as legal advisor.

Sperry Mitchell & Company served as M&A advisor to V-TEK, and Blank Rome LLP served as legal advisor.

The securities referenced in this press release as part of the acquisition have not been registered under the Securities Act of 1933, as amended (“Securities Act”), or any state or other applicable jurisdiction’s securities laws. They may not be offered or sold absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state or other jurisdictions’ securities laws.

This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, nor may there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Data I/O Corporation

Since 1972, Data I/O has developed innovative solutions to enable the design and manufacture of electronic products for automotive, Internet-of-Things, medical, wireless, consumer electronics, industrial controls and other electronics devices. Today, our customers use Data I/O’s data programming solutions and security deployment platform to secure the global electronics supply chain and protect IoT device intellectual property from point of inception to deployment in the field. OEMs of any size can program and securely provision devices from early samples all the way to high volume production prior to shipping semiconductor devices to a manufacturing line. Data I/O enables customers to reliably, securely, and cost-effectively bring innovative new products to life. These solutions are backed by a portfolio of patents and a global network of Data I/O support and service professionals, ensuring success for our customers. Learn more at dataio.com/Company/Patents.

Learn more at dataio.com

Safe Harbor/Forward Looking Statements and Disclosure Information

The Company cautions you that statements contained in this press release regarding matters that are not historical facts are forward-looking statements, including the benefits anticipated from the acquisition. Such forward-looking statements involve risks, assumptions and uncertainties. Statements in this news release may be construed as a prediction of future operations and performance or events are forward-looking statements which involve known and unknown risks, uncertainties and other factors which may cause actual results to differ materially from those expressed or implied by such statements.

Forward-looking statement disclaimers also apply to the timing and contributions of acquisitions, acquisition synergies, the demand for the Company’s products, the impact from geopolitical conditions including any related international trade restrictions, and cybersecurity incidents and the possibility that the Company’s containment and remediation efforts may be unsuccessful or becomes a challenging force in maintaining market share. Factors that may impact the Company’s operations and finances include uncertainties as to the ability to record revenues based upon the timing of product deliveries, market acceptance of Edge AI, shipping availability, installations and acceptance, accrual of expenses, coronavirus or other business interruptions, changes in economic conditions, part shortages, business disruptions and other risks including those described in the Company’s 10-K, 10-Q and other periodic filings with the Securities and Exchange Commission (SEC), press releases and other communications.

Data I/O may use its website (www.dataio.com) and investor relations page (www.dataio.com/Company/Investor-Relations), its X account (@DataIO_Company), and its LinkedIn page (linkedin.com/company/data-io) to disclose material non-public information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors and other interested parties should monitor these sites, in addition to following Data I/O’s press releases, Securities and Exchange Commission (SEC) filings, public conference calls and public presentations/webcasts.

*References in this press release are made to non-GAAP (Generally Accepted Accounting Principles) financial measures, including profitability and operating/net income excluding one-time items, EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization), Adjusted EBITDA (AEBITDA), which excludes equity compensation, and AEBITDA excluding one-time items. Reconciliations are provided in the tables of this press release. Non-GAAP financial measures, such as EBITDA and Adjusted EBITDA, excluding equity compensation, and other one-time investments/expenses should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. We believe that these non-GAAP financial measures provide meaningful supplemental information regarding the Company’s results and facilitate the comparison of results.

Media Contact
Data I/O Corporation
Jennifer Higgins
Director Corporate Marketing
higginj@dataio.com
+1-425-867-6922

Investor Contact
Darrow Associates, Inc.
Jordan Darrow
jdarrow@darrowir.com
+1-631-766-4528

MONTREAL, Oct. 21, 2026 (GLOBE NEWSWIRE) — Gildan Activewear Inc. (GIL; TSX and NYSE) will report its 2026 third quarter financial and operating results on Thursday, November 5, 2026. A press release will be issued before markets open, and a conference call is scheduled on that same day at 8:30 AM ET to discuss the Company’s results.

Glenn J. Chamandy, Gildan’s President and Chief Executive Officer, Luca Barile, Executive Vice President, Chief Financial Officer, Chuck Ward, Executive Vice President, Chief Commercial Officer and Jessy Hayem, Senior Vice President, Head of Investor Relations and Global Communications, will participate in this call intended for financial analysts and institutional investors.

The conference call can be accessed by dialing (800) 715-9871 (Canada & U.S.) or (646) 307-1963 (international) and entering passcode 9609115#. A replay will be available for 7 days starting at 12:30 PM EST by dialing (800) 770-2030 (Canada & U.S.) or (609) 800-9909 (international) and entering the same passcode. A live audio webcast of the conference call, as well as the replay, will be available at the following link: Gildan Q3 2026 audio webcast.

About Gildan
Gildan is a leading manufacturer of everyday basic apparel. The Company’s product offering includes activewear, underwear, socks, and intimates sold to a broad range of customers, including wholesale distributors, screenprinters, embellishers, retailers or e-commerce platforms, as well as global lifestyle brand companies and directly to consumers. Gildan markets its products in North America, Europe, Asia Pacific, and Latin America, under a diversified portfolio of Company-owned brands including Gildan®, Hanes®, Comfort Colors®, American Apparel®, ALLPRO™, GOLDTOE®, Peds®, Bali®, Playtex®, Maidenform®, Bonds®, as well as Champion™ which is under an exclusive licensing agreement for the printwear channel in the U.S. and Canada and Polo Ralph Lauren® also under a licensing agreement.

Gildan owns and operates vertically integrated, large-scale manufacturing facilities which are primarily located in Central America, the Caribbean, North America, and Asia. Gildan integrates industry-leading labour, environmental, and governance practices into its operations and supply chain under a sustainability program that is aligned with its long-term business strategy. More information about Gildan and its sustainability commitments and initiatives can be found at www.gildancorp.com

Investor inquiries: Jessy Hayem, CFA Senior Vice-President, Head of Investor Relations and Global Communications (514) 744-8511 investors@gildan.com

Media inquiries: Jonathan Binder Director, Corporate Communications (336) 519-6330 communications@gildan.com

HOUSTON, Oct. 21, 2026 (GLOBE NEWSWIRE) — Westlake Chemical Partners (NYSE: WLKP) will release its third quarter 2026 earnings prior to the market opening on Wednesday, November 4, 2026. The company will host a conference call at 1:00 p.m. Eastern Time (12:00 p.m. Central Time) on the same day to discuss the earnings release.

To access the conference by phone, it is necessary to pre-register at https://register-conf.media-server.com/register/BI3f3870a5aac84874bbbc7d18dbd188bc. Once registered, you will receive a phone number and unique PIN number. When you dial in, you will input the PIN number to be placed into the call.

The conference call and replay will be available via webcast at https://edge.media-server.com/mmc/p/so37ydoy and the earnings release can be obtained via the company’s Web page at https://investors.wlkpartners.com.

About Westlake Chemical Partners:

Westlake Chemical Partners is a limited partnership formed by Westlake Corporation to operate, acquire and develop ethylene production facilities and other qualified assets. Headquartered in Houston, the Partnership owns an 22.8% interest in Westlake Chemical OpCo LP. Westlake Chemical OpCo LP’s assets consist of three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana and an ethylene pipeline. For more information about Westlake Chemical Partners LP, please visit http://www.wlkpartners.com.

For Further Information Contact:
Media Relations – L. Ben Ederington – 713.585.2900
Investor Relations – Jonathan Baksht – 713.585.2900

Seed orders for the FY 2027 season up more than 100% Ytd, targeting 50%+ Yoy revenue growth for FY 2027

BEIJING, Oct. 21, 2026 (GLOBE NEWSWIRE) — Origin Agritech Limited (NASDAQ: SEED) (“Origin” or the “Company”), a leading Chinese agricultural technology company, today issued a letter to shareholders from Chief Executive Officer Weibin Yan as the Company enters fiscal year 2027. The full text follows.

Dear Fellow Shareholders,

Two years ago, in August 2024, I returned to Origin Agritech as Chief Executive Officer with a clear objective: to strengthen our position in China’s corn seed industry and build a foundation for sustainable growth.. We closed fiscal 2026 on September 30 with the first phase of our strategic plan complete. Early indicators are encouraging: customer advance payments and seed preorders for spring planting are up more than 100% year-over-year to date. I would like to share the progress we have made, the opportunities ahead, and how we intend to build on this momentum.

Building the Foundation for Growth: The Restructuring Stage

When I rejoined Origin in August 2024, we established a three-stage development plan. Fiscal 2025 and 2026 comprised the Restructuring Stage, during which we made substantial progress. We strengthened our leadership team and expanded sales and marketing across China’s major corn seed regions, re-entering Northeast China last year and launching operations in Guizhou in June this year. We launched four new corn varieties in August 2025, secured exclusive nationwide commercialization rights to Zhongdan 6202 one year later, and began introducing Bangzhongbang 889 for FY 2027.

We upgraded R&D stations in Beijing and Sanya, opened new stations in Zhengzhou and Guizhou. We obtained gene-editing trait authorizations, partnered with China Agricultural University and the Beijing Academy of Agricultural and Forestry Sciences to advance biotechnology commercialization, obtained Beijing Origin’s seed production and operation license, and implemented an AI-assisted information management system. We also completed a sale-and-leaseback of our Xinjiang seed production subsidiary, unlocking capital while retaining operational access, strengthening liquidity without shareholder dilution.

What to expect in FY 2027: The Strong Growth Stage Begins

Fiscal 2027 through fiscal 2029 marks our Strong Growth Stage. The new fiscal 2027 season started very well with our new seed varieties have receiving encouraging market responses across our main business regions. Advance payments are up more than 100% year-over-year in this early season. Building on this momentum, we expect our operating cash flow from the seed business to more than double year over year in FY 2027.

Three engines are driving that growth: our variety portfolio, led by Zhongdan 6202 and Bangzhongbang 889, with new varieties supporting central China; our regional expansion, including full seasons in Northeast China and Guizhou; and most importantly, our technology platform is greatly improving our R&D efficiency, and the planned Origin Agri-tech Agent will greatly accelerate our engagement with the farmers to improve farmer productivity, deepen and broaden our client relationships.

Looking ahead, we are pursuing organic growth and evaluating M&A opportunities in China and Southeast Asia, supported by our international capital platform. For FY 2028 and FY 2029, we target at least 50% year-over-year organic business growth as our new varieties expand across the Huanghuai-Hai belt and China’s Northeast, Northwest, and Southwest regions.

A personal note

I returned to Origin because I believe China’s corn seed market offers significant opportunities for companies with strong genetics, effective distribution, and innovative technology. With more than 200,000 germplasm accessions, authorized gene-edited traits, a growing variety portfolio, and an expanded sales network,strong engagement with the leading experts in the industry, Origin is building the capabilities to capture these opportunities. Our goal is to become one of  China’s leading corn seed companies within five years, and the more than 100% year-over-year increase in advance payments to date is an encouraging early indicator of customer demand. My own capital is invested alongside yours.

Thanks for your investment and attention, I look forward to speaking with you on our next call.

Sincerely,
Weibin Yan
Chief Executive Officer
Origin Agritech Limited

About Origin Agritech Limited

Origin Agritech Limited, founded in 1997 and headquartered at the Origin R&D Center in Songzhuang, Tongzhou, Beijing, is a leading Chinese agricultural technology company. In crop seed biotechnology, Origin Agritech’s phytase corn was the first transgenic corn to receive a Biosafety Certificate from China’s Ministry of Agriculture. Over the years, Origin has established a robust biotechnology seed pipeline, including products with glyphosate tolerance and Bt (pest resistance) traits. For further information, please visit the Company’s website at https://originagritech.com. The Company also maintains an X account to update investors on Company and industry developments, available at https://x.com/origin_agritech.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s expectations for advance payments and seed sales in fiscal 2027, the launch and market acceptance of Zhongdan 6202, Bangzhongbang 889, and other varieties, the launch, timing, and expected benefits of the Company’s Farming AI Agent, and AI-asisted information management system, the Company’s three-stage strategic plan and the targets for each stage, the use of capital from the sale and leaseback of the Xinjiang subsidiary and its effect on the Company’s results and liquidity, regulatory and commercial milestones for new and biotechnology-derived varieties, potential acquisitions and international expansion, and the Company’s strategic goals. Words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “will,” “would,” “target,” and similar expressions identify forward-looking statements. These statements involve known and unknown risks and uncertainties, including the risk that advance payments do not convert into seed sales at the level or timing expected, delays in or failure to achieve regulatory and commercial milestones, grower adoption of the Company’s varieties, seed production yields and weather conditions, competitive variety introductions, pricing pressure in the Chinese seed market, regulatory and agricultural policy developments in China, currency fluctuation, risks associated with international operations and licensing approvals, and the Company’s ability to fund and execute the plans described above, which may cause actual results to differ materially from those expressed or implied. Forward-looking statements are not guarantees of future performance. Origin Agritech undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by securities and other applicable laws.

For more information, please contact:

Origin Agritech Limited Contact:

Kate Lang (Mandarin/English)
Director of Investor Relations
Phone: +86 186-1839-3368
Email: bing.lang@originseed.com.cn

Investor Relations Contact:

Matthew Abenante, IRC
President
Strategic Investor Relations LLC
Tel: 347-947-2093
Email: matthew@strategic-ir.com